SCHEMBL17828424

SCHEMBL17828424

CN[C@H](C(=O)CI)C(C)C

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.34
CA12 O43570 1/20 0.30
CA14 Q9ULX7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12282873 0.78 SMN1; SMN2 (0.32) DPP4CA12CA14
SCHEMBL14942955 0.78 SMN1; SMN2 (0.32) DPP4CA12CA14
SCHEMBL10140506 0.78 SMN1; SMN2 (0.32) DPP4CA12CA14
SCHEMBL20403663 0.76 DPP4 (0.31) DPP4CA12CA14
SCHEMBL17020280 0.74 PLA2G2A (0.37) DPP4
SCHEMBL31629142 0.70 CA12 (0.34) CA12CA14
SCHEMBL43661 0.69
SCHEMBL10140649 0.69 CA12 (0.34) DPP4CA12CA14
SCHEMBL8171264 0.69
SCHEMBL716843 0.69 SMN1; SMN2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016094837-A2 ANTI-C10ORF54 ANTIBODIES AND USES THEREOF IGENICA BIOTHERAPEUTICS, INC. (US) 2016-06-16 WO disclosed